JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schornberg, K.
Right arrow Articles by White, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schornberg, K.
Right arrow Articles by White, J.

 Previous Article  |  Next Article 

Journal of Virology, April 2006, p. 4174-4178, Vol. 80, No. 8
0022-538X/06/$08.00+0     doi:10.1128/JVI.80.8.4174-4178.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus Glycoprotein

Kathryn Schornberg,1 Shutoku Matsuyama,2 Kirsten Kabsch,2 Sue Delos,2 Amy Bouton,1*,{dagger} and Judith White1,2*

Departments of Microbiology,1 Cell Biology, University of Virginia, Charlottesville, Virginia 22908-07342

Received 17 December 2005/ Accepted 29 January 2006

Using chemical inhibitors and small interfering RNA (siRNA), we have confirmed roles for cathepsin B (CatB) and cathepsin L (CatL) in Ebola virus glycoprotein (GP)-mediated infection. Treatment of Ebola virus GP pseudovirions with CatB and CatL converts GP1 from a 130-kDa to a 19-kDa species. Virus with 19-kDa GP1 displays significantly enhanced infection and is largely resistant to the effects of the CatB inhibitor and siRNA, but it still requires a low-pH-dependent endosomal/lysosomal function. These and other results support a model in which CatB and CatL prime GP by generating a 19-kDa intermediate that can be acted upon by an as yet unidentified endosomal/lysosomal enzyme to trigger fusion.

* Corresponding author. Mailing address: University of Virginia, 1300 Jefferson Park Ave., Charlottesville, VA 22908-0734. Phone: (434) 924-2593. Fax: (434) 982-3912. E-mail for A. Bouton: ahb8y{at}virginia.edu; E-mail for J. White: jw7g{at}virginia.edu.

{dagger} Equal contributors.

Journal of Virology, April 2006, p. 4174-4178, Vol. 80, No. 8
0022-538X/06/$08.00+0     doi:10.1128/JVI.80.8.4174-4178.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.